Societal Cdmo Inc Quick Ratio (SCTL) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Societal Cdmo Inc   (NASDAQ: SCTL)

Societal Cdmo Inc 's Quick Ratio

SCTL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2023, Quick Ratio fell to 0.17 a new company low.

Within Major Pharmaceutical Preparations industry 440 other companies have achieved higher Quick Ratio than Societal Cdmo Inc in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 2715 to 3537.

Explain Quick Ratio?
How much Cash & cash equivalents SCTL´s has?
What are SCTL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCTL Quick Ratio (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4
Y / Y Current Liabilities Change 124.96 % 56.61 % 49.8 % 85.58 % 30.27 %
Y / Y Cash & cash equivalent Change -46.02 % -29.55 % -69.62 % -58.8 % -40.54 %
Quick Ratio MRQ 0.17 0.4 0.26 0.34 0.69
SCTL's Total Ranking # 3537 # 2715 # 3149 # 2870 # 2331
Seq. Current Liabilities Change 138.17 % 12.68 % -1.25 % -15.11 % 65.81 %
Seq. Cash & cash equivalent Change -0.75 % 73.42 % -25.27 % -58.03 % 29.52 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 441
Healthcare Sector # 868
Overall Market # 3537


Quick Ratio Statistics
High Average Low
36.26 4.17 0.17
(Mar 31 2014)   (Dec 31 2023)




Financial Statements
Societal Cdmo Inc 's Current Liabilities $ 49 Millions Visit SCTL's Balance sheet
Societal Cdmo Inc 's Cash & cash equivalent $ 8 Millions Visit SCTL's Balance sheet
Source of SCTL's Sales Visit SCTL's Sales by Geography


Cumulative Societal Cdmo Inc 's Quick Ratio

SCTL's Quick Ratio for the trailling 12 Months

SCTL Quick Ratio

 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 86.3 % 52.1 % 41.32 % 49.63 % 35.88 %
Y / Y Cash & cash equivalent TTM Growth -52.47 % -49.45 % -52.72 % -55.93 % -45.91 %
Quick Ratio TTM 0.26 0.43 0.53 0.74 1.01
Total Ranking TTM # 4038 # 3984 # 3868 # 2709 # 664
Seq. Current Liabilities TTM Growth 34.41 % 10.38 % 9.25 % 14.94 % 9.73 %
Seq. Cash & cash equivalent TTM Growth -20.21 % -9.11 % -22.29 % -15.67 % -15.13 %

Quick ratio ranking by company, industry and sector >> Back to SCTL Financial Strength Comparisons >> Go to Compare SCTL Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2023 to $48.88 millions, cumulative Quick Ratio decreased to 0.26 below the Societal Cdmo Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 488 other companies have achieved higher Quick Ratio than Societal Cdmo Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3984 to 4038.

Explain Quick Ratio?
How much Cash & cash equivalents SCTL´s has?
What are SCTL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 489
Healthcare Sector # 997
Within the Market # 4038


trailing twelve months Quick Ratio Statistics
High Average Low
3.71 1.81 0.25
(Jun 30 2017)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Dar Bioscience Inc   0.45 $ 10.476  Millions$ 23.241  Millions
Biophytis Sa  0.45 $ 6.235  Millions$ 13.849  Millions
Actuate Therapeutics Inc   0.45 $ 2.959  Millions$ 6.643  Millions
Akebia Therapeutics Inc   0.43 $ 42.925  Millions$ 99.870  Millions
Entrada Therapeutics Inc   0.43 $ 67.602  Millions$ 158.796  Millions
Mustang Bio inc   0.42 $ 6.234  Millions$ 14.756  Millions
Evoke Pharma Inc   0.42 $ 4.739  Millions$ 11.309  Millions
Optinose Inc   0.42 $ 73.684  Millions$ 176.524  Millions
Bio Green Med Solution Inc   0.41 $ 3.378  Millions$ 8.161  Millions
Sonnet Biotherapeutics Holdings Inc   0.41 $ 2.274  Millions$ 5.525  Millions
Hcw Biologics Inc   0.41 $ 3.595  Millions$ 8.748  Millions
Pharming Group N v   0.41 $ 61.741  Millions$ 150.496  Millions
Elanco Animal Health Incorporated  0.40 $ 352.000  Millions$ 874.000  Millions
Intelgenx Technologies Corp   0.40 $ 2.357  Millions$ 5.866  Millions
Bausch Health Companies Inc   0.39 $ 947.000  Millions$ 2,435.000  Millions
Cellectar Biosciences Inc   0.38 $ 9.565  Millions$ 25.300  Millions
Prestige Consumer Healthcare Inc   0.36 $ 58.489  Millions$ 160.715  Millions
Pfizer Inc  0.35 $ 17,403.000  Millions$ 50,247.000  Millions
Abbvie Inc   0.34 $ 12,816.000  Millions$ 37,841.000  Millions
Ensysce Biosciences Inc   0.34 $ 1.124  Millions$ 3.333  Millions
Fibrobiologics Inc   0.34 $ 2.266  Millions$ 6.747  Millions
Aytu Biopharma Inc  0.33 $ 22.985  Millions$ 69.015  Millions
International Stem Cell Corporation  0.33 $ 1.588  Millions$ 4.832  Millions
Exicure Inc   0.33 $ 0.816  Millions$ 2.510  Millions
The Greater Cannabis Company Inc   0.32 $ 0.167  Millions$ 0.518  Millions
Zyversa Therapeutics Inc   0.32 $ 3.236  Millions$ 10.195  Millions
Quantum Biopharma Ltd   0.31 $ 2.757  Millions$ 8.761  Millions
Vbi Vaccines Inc  0.31 $ 23.685  Millions$ 77.410  Millions
Keenova Therapeutics Plc  0.30 $ 162.400  Millions$ 534.500  Millions
Nrx Pharmaceuticals Inc   0.30 $ 4.595  Millions$ 15.169  Millions

Date modified: 2026-09-08T15:11:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.